Scientists now able to predict response to radium-223 treatment in prostate cancer bone metastases
Target lesion measurements in a 65-year-old metastatic castrate-resistant prostate cancer patient, 5 target lesions on b900 DWI, ADC (with green segmentation), T1-weighted and 18F-NaF PET/CT fusion, and PET (delineated) images; apparent difference in lesion size between DWI and PET images may relate to the difference in functional properties used to generate image contrast, variance in patient…